alexa Early Identification And Prevention Of Drug-to-drug Interactions In A Tertiary Care Hospital | 22942
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials

Radhika Soanker and Subbalaxmi M V S
ScientificTracks Abstracts: J Pharmacovigilance
DOI: 10.4172/2329-6887.S1.012
Abstract
Introduction: Drug-to-Drug Interactions (DDIs) is a significant factor that modifies the desired effect of a drug, producing either sub therapeutic effect or toxicity. The probability increases with an increase in number of drugs. If identified early, then undesired effects can be prevented. This presentation emphasizes the importance of early identification of DDIs. Methods: In our hospital, clinicians refer cases to the Dept of Clinical Pharmacology & Therapeutics, whenever they anticipate drug related therapeutic issues of these Prescriptions referred in last two years, only those with potential DDIs are presented. On comprehensive review, the opinion regarding the suspected DDIs, with anticipated consequences and further management was suggested. Results: Total prescriptions reviewed were 124, of which 21 had potential DDIs. 12 were due to microsomal inhibition/ induction. The most common drugs implicated being Ritonavir and rifampcin. 8 & 13 prescriptions were related to Adverse Drug Reactions (ADRs) and sub therapeutic effect respectively. In 8 cases, co administration of interacting drugs was to be avoided. In 10 cases, as potential DDIs were identified on day one, loss of efficacy was prevented in 6 cases and ADRs in 4 cases. Conclusion: As, when drug-drug Interactions were identified on day one, significant number of patients achieved successfully therapeutic outcomes. Clinicians should be vigilant regarding DDIs when more than 2 drugs are prescribed and if possible refer the cases to pharmacologists for early identification.
Biography
Radhika Soanker, Assistant Professor, Dept of Clinical Pharmacology & Therapeutics (CP&T), Nizam?s Institute of Medical Sciences (NIMS) has done MBBS & MD (Pharmacology) from Kakatiya Medical College and pursued DM (Clinical Pharmacology & Therapeutics) from NIMS. Published and presented papers, delivered invited lectures as resource person in workshops and CMEs and coordinated conduct of pharmacodynamic workshops in NIMS under ICMR auspices. Specially interested in individualizing patient dosage regimens by prescription review, suggesting necessary dosage adjustments, suspected drug interactions, rechallenge solutions for Adverse Drug Reactions and in developing pharmacodynamic methods for evaluation of drug effects on different systems apart from conducting clinical trials both sponsored and academic initiated.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immunomicrob[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7